Page last updated: 2024-11-01

ondansetron and Glucose Intolerance

ondansetron has been researched along with Glucose Intolerance in 2 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Glucose Intolerance: A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.

Research Excerpts

ExcerptRelevanceReference
"Ondansetron is an antagonist of 5-HT3 receptors mostly used as an antiemetic yet known to modulate metabolism and appetite."1.38Differential effects of 5-HT3 receptor antagonist on lipid profile in spontaneously hypertensive rat and chromosome 8 congenic strain. ( Kren, V; Krenova, D; Krupkova, M; Liska, F; Seda, O; Sedova, L, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mandhane, S1
Nayak, P1
Soni, D1
Jain, S1
Ashton, JC1
Rajamannar, T1
Krupkova, M1
Sedova, L1
Liska, F1
Krenova, D1
Kren, V1
Seda, O1

Other Studies

2 other studies available for ondansetron and Glucose Intolerance

ArticleYear
Induction of glucose intolerance by acute administration of rimonabant.
    Pharmacology, 2012, Volume: 89, Issue:5-6

    Topics: Administration, Oral; Animals; Benzoxazines; Blood Glucose; Dopamine Antagonists; Eating; Fenclonine

2012
Differential effects of 5-HT3 receptor antagonist on lipid profile in spontaneously hypertensive rat and chromosome 8 congenic strain.
    Neuro endocrinology letters, 2012, Volume: 33 Suppl 2

    Topics: Animals; Animals, Congenic; Chromosomes, Mammalian; Disease Models, Animal; Glucose Intolerance; Hyp

2012